RING-EXPANDED NUCLEOSIDES AND NUCLEOTIDES

(19)

(11)

EP 0 724 587 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	29.01.2003 Bulletin 2003/05

(45)	Mention of the grant of the patent:
	04.09.2002 Bulletin 2002/36

(21)	Application number: 94929358.3

(22)	Date of filing: 29.09.1994

(51)	International Patent Classification (IPC)⁷: C07H 19/04, C07H 19/052, C07D 487/04, A61K 31/70

(86)	International application number:
	PCT/US9410/905

(87)	International publication number:
	WO 9500/9175 (06.04.1995 Gazette 1995/15)

(54)	RING-EXPANDED NUCLEOSIDES AND NUCLEOTIDES NUKLEOSIDE UND NUKLEOTIDE MIT VERGRÖSSERTEN RINGEN NUCLEOSIDES ET NUCLEOTIDES A CYCLE ELARGI

(84)	Designated Contracting States:
	AT BE CH DE DK ES FR GB GR IE IT LI LU MC NL PT SE

(30)

Priority:

29.09.1993 US 128212

(43)	Date of publication of application:
	07.08.1996 Bulletin 1996/32

(60)	Divisional application:
	02001587.1 / 1227103

(73)	Proprietors:
	Nabi Boca Raton, FL 33487 (US) University of Maryland Baltimore County Baltimore, Maryland 21250 (US)

(72)	Inventors:
	Burns, Barry Owings Mills MD 21117 (US) Hosmane, Ramchandra Columbia MD 21045 (US)

(74)	Representative: Marshall, Monica Anne
	J.A. KEMP & CO. 14 South Square Gray's Inn London WC1R 5JJ London WC1R 5JJ (GB)

(56)

References cited: :

US-A- 4 151 347
US-A- 4 713 372

US-A- 4 163 839
US-A- 4 935 505

JOURNAL OF HETEROCYCLIC CHEMISTRY, vol. 30, no. 5, October 1993, pages 1453-1462, XP000605435 A.BHAN ET AL.: "Reactions of Ring-Expanded Xanthines Containing the Imidazo(4,5-e)(1,4)diazepine Ring System "

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).